All In Biotech

Free tool

FAERS Monitor: Soma

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 011792 or its brand name (Soma, Carisoprodol). Reports on generic versions are filed under their own applications.

Reports

19,021

Serious

13,059

69% of reports

Hospitalization

4,651

Death reported

4,017

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pain1,624
  • completed suicide1,459
  • drug ineffective1,319
  • nausea1,294
  • headache1,102
  • anxiety992
  • depression990
  • fatigue989
  • toxicity to various agents917
  • insomnia829
  • vomiting819
  • drug dependence797
  • fall789
  • dyspnoea747
  • overdose734

Reports by year received

View as table
YearReports
2004607
2005750
2006601
2007511
2008671
2009763
20101,289
20111,148
20121,433
20131,160
2014978
20151,366
20161,602
20171,086
20181,085
20191,059
20201,034
2021600
2022354
2023275
2024268
2025207
2026173

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,138 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
completed suicideSignal1,45919.718.725,510
toxicity to various agentsSignal9176.05.73,862
drug dependenceSignal7975.55.12,940
depressionSignal9904.84.53,020
anxietySignal9923.93.62,125
overdoseSignal7343.83.51,503
insomniaSignal8293.43.21,453
painSignal1,6242.92.82,117
fallSignal7892.62.5803
headache1,1021.91.8520
vomiting8191.91.8372
nausea1,2941.81.7485
dyspnoea7471.51.4111
fatigue9891.41.3119
drug ineffective1,3191.11.114

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.